Registry for people with Castleman disease worldwide
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial is a worldwide registry that collects basic medical information from people diagnosed with Castleman disease. It helps researchers learn about real-world care and outcomes across different ages and care settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can be any age
- You have a pathology (tissue test) report suggesting Castleman disease
- You must be able to sign consent electronically (according to local rules)
- If you are deceased, the study team may include you if the pathology report can be provided or found
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about adults with plasma cell disorders (conditions involving abnormal antibody-producing cells). It may help researchers understand these diseases better and improve future care by tracking patients over time.
This trial tests a medication called nintedanib for people with a rare condition called Unicentric Castleman disease (one area of lymph nodes affected) that cannot be fully removed by surgery. The goal is to see if nintedanib can help shrink the tumor or control symptoms.
This trial is looking back at the medical records of people with a rare condition called Castleman's disease to see how well the drug Siltuximab worked for them in everyday hospital care, not in a research setting. The goal is to learn more about how safe and effective the drug can be for patients in real life.
This study looks at how KSHV-associated multicentric Castleman disease naturally progresses over time, without necessarily testing a new treatment. It may help doctors better understand the disease and what changes to watch for, which could guide future care.
This is a registry (a research database) for people with Erdheim-Chester disease and other related “histiocytosis” conditions. It collects past and future medical information to better understand these illnesses and support future research.
This study tests new methods to diagnose lymphoma and multicentric castleman disease, which are conditions that can affect people with HIV. It may help find these diseases earlier and more accurately.
Hear when a new Castleman Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.